HCC Is promoted by bacterial translocation and TLR-4 signaling: A new paradigm for chemoprevention and management

Authors

  • Sara Toffanin,

    1. Mount Sinai Liver Cancer Program (Division of Liver Diseases, Department of Medicine; Tisch Cancer Institute; Division of Surgical Oncology, Department of Surgery; Transplant Institute; Department of Pathology) New York, NY
    2. Hepato-Oncology Group Department of Surgery and Experimental Oncology National Cancer Institute Milan, Italy
    Search for more papers by this author
  • Helena Cornella,

    1. Mount Sinai Liver Cancer Program (Division of Liver Diseases, Department of Medicine; Tisch Cancer Institute; Division of Surgical Oncology, Department of Surgery; Transplant Institute; Department of Pathology) New York, NY
    2. HCC Translational Research Laboratory Barcelona Clinic Liver Cancer Group Liver Unit Hospital Clínic IDIBAPS, CIBERehd University of Barcelona Catalonia, Spain
    Search for more papers by this author
  • Andrew Harrington,

    1. Mount Sinai Liver Cancer Program (Division of Liver Diseases, Department of Medicine; Tisch Cancer Institute; Division of Surgical Oncology, Department of Surgery; Transplant Institute; Department of Pathology) New York, NY
    Search for more papers by this author
  • Josep M. Llovet

    1. Mount Sinai Liver Cancer Program (Division of Liver Diseases, Department of Medicine; Tisch Cancer Institute; Division of Surgical Oncology, Department of Surgery; Transplant Institute; Department of Pathology) New York, NY
    2. HCC Translational Research Laboratory Barcelona Clinic Liver Cancer Group Liver Unit Hospital Clínic IDIBAPS, CIBERehd University of Barcelona Catalonia, Spain
    3. Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary